Regenosome's Breakthroughs in Longevity and Nanoparticle Technology at GATEWAY Tech TAKANAWA 2026

Innovations in Longevity and Brain Delivery by Regenosome at GATEWAY Tech TAKANAWA 2026

Regenosome Inc., a longevity tech venture affiliated with Space Seed Holdings, made significant strides at the recent GATEWAY Tech TAKANAWA 2026. Held on May 13-14, 2026, at the TAKANAWA GATEWAY Convention Center, this event was organized by East Japan Railway Company (JR East) and aimed to highlight cutting-edge technology and innovation.

The focus of Regenosome is on developing nanoparticles intended to combat the root causes of aging. The company is particularly dedicated to utilizing low-oxygen environments to enhance health and longevity. At the event, Regenosome participated through a series of panel discussions, exhibit booths, and rapid-fire pitches, providing insights into their pioneering research.